| Literature DB >> 33167308 |
Carla Morer1, Alfredo Michan-Doña2, Antonio Alvarez-Badillo3, Pilar Zuluaga4, Francisco Maraver5.
Abstract
Strokes are a leading cause of disability in developed countries. Patients with disabilities need rehabilitation to improve their physical functioning, mental status, and quality of life. Currently, no high-quality evidence can be found attesting the benefits of any of the interventions that are nowadays used. Water-based exercise may improve the physical conditions and quality of life of people in the post-stroke phase. The objective of this study is to test whether aquatic therapy in an enriched environment at the seaside (a thalassotherapy center) could play a role in this condition. A quasi-experimental prospective study consisting of a specific program assessed 62 patients with a mild-moderate disability pre- and post-2 weeks of intensive treatment. They followed a thalassotherapy regimen including aquatic therapy in a sea water pool at 32-34 °C for 45 min daily five times a week. The outcomes measured were the Berg Balance scale, the Timed Up and Go test, the 10-meter walking test, the 6-min walking test, the Pain Visual Analogue Scale, the WHO Well-being index, EuroQoL VAS and EuroQoL 5D. We observed a significant improvement in all outcomes measured (p < 0.001, except mobility EuroQoL p < 0.05), except in the other four dimensions of the EuroQoL 5D and 10-metre walking test (NS).Entities:
Keywords: aquatic therapy; balance; gait; pain; quality of life; stroke; thalassotherapy
Year: 2020 PMID: 33167308 PMCID: PMC7663820 DOI: 10.3390/ijerph17218163
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Study design flow chart.
Thalassotherapy factor: seawater.
| Seawater | Jan | April | July | Oct | Mean |
|---|---|---|---|---|---|
| Conductivity to 25 °C (μS·cm−1) | 67,300 | 65,600 | 66,700 | 67,280 | 66,720 |
| pH | 7.4 | 7.5 | 7.5 | 7.6 | 7.5 |
| Li+ (mg/L) | 0.09 | 0.08 | 0.09 | 0.09 | 0.09 |
| Na+ (mg/L) | 11,343 | 11,570 | 11,643 | 11,426 | 11,496 |
| K+ (mg/L) | 472 | 459 | 470 | 444 | 462 |
| Mg2+ (mg/L) | 1405 | 1417 | 1431 | 1331 | 1396 |
| Ca2+ (mg/L) | 562 | 537 | 511 | 548 | 540 |
| F− (mg/L) | 1.5 | 1.5 | 1.4 | 1.5 | 1.5 |
| Cl− (mg/L) | 19,541 | 19,103 | 19,586 | 20,482 | 19,678 |
| Br− (mg/L) | 6.7 | 6.6 | 6.0 | 6.1 | 6.4 |
| HCO3− (mg/L) | 134 | 140 | 134 | 140 | 137 |
| NO3− (mg/L) | 10 | 10 | 10 | 10 | 10 |
| SO42− (mg/L) | 2833 | 2713 | 2837 | 2741 | 2782 |
Thalassotherapy factors: sea climate and sea peloid.
| Sea climate | Jan | Feb | Mar | April | May | June | July | Aug | Sept | Oct | Nov | Dec | Mean |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Temperature | |||||||||||||
| Average temp. (°C) | 11.1 | 12 | 14.2 | 16.2 | 19.3 | 23.1 | 25.8 | 26.2 | 23.7 | 19.5 | 15.4 | 12.4 | 18.2 |
| Min. temperature (°C) | 6 | 6.7 | 8.8 | 11 | 13.9 | 17.5 | 19.9 | 20.4 | 18.1 | 14.2 | 10.2 | 7.6 | 12.9 |
| Max temperature (°C) | 16.2 | 17.3 | 19.7 | 21.5 | 24.8 | 28.8 | 31.7 | 32 | 29.4 | 24.8 | 20.6 | 17.3 | 23.7 |
| Pluviometry | |||||||||||||
| Precipitation (mm) | 24 | 19 | 23 | 27 | 25 | 13 | 4 | 7 | 29 | 55 | 38 | 35 | 24.9 |
|
| |||||||||||||
| Centesimal composition | Instrumental texture | Thermal properties | |||||||||||
| Water (%) | 59.9 | Hardness (g) | 45 | Specific heat (Cp) | 2.9 | ||||||||
| Solids (%) | 40.1 | Adhesiveness (g s) | 548 | Relaxation time tr (s) | 498 | ||||||||
| Ash (%) | 35.8 | Cohesiveness | 0.96 | Heat amount Q (J) | 16,644 | ||||||||
| Ash/Solids | 0.88 | Adhesiveness/Hardness | 12.10 | Heat flow Φ (J/s) | 33.4 | ||||||||
Description of the participants.
| Characteristics | Participants |
|---|---|
| Sex | Females 24 (38.7) |
| Males 38 (61.3) | |
| Age (years) | Min. 49 |
| Max. 87 | |
| Mean 69 | |
| Stroke type | Ischemic 47 (75.8) |
| Hemorrhagic 15 (24.2) | |
| Stage | <6 months: 1 (1.6) |
| 6 months–12 months: 11 (17.7) | |
| >1 year: 50 (80.7) | |
| Barthel Scale | Min. 15 |
| Max. 100 | |
| Mean 70.3 | |
| Morse Fall Scale | Min. 20 |
| Max. 90 | |
| Mean 67.7 | |
| Downton Scale | Min. 3 |
| Max. 7 | |
| Mean 4.24 | |
| Rankin Scale | Min. 1 |
| Max. 3 | |
| Mean 1.92 |
Pre- and post-intervention scores.
| Min. | Max. | Mean | Sd | Median | ||
|---|---|---|---|---|---|---|
| BBS | ||||||
| Pre | 0.0 | 56.0 | 25.8 | 19.2 | 28.5 | |
| Post | 0.0 | 56.0 | 31.3 | 19.6 | 36.0 | |
| Mean diff. | −2.0 | 23.0 | 5.5 | 5.2 | 5.0 | |
| TUG | ||||||
| Pre | 6.0 | 240.0 | 49.2 | 45.8 | 43.0 | |
| Post | 6.0 | 144.0 | 39.7 | 31.3 | 36.0 | |
| Mean diff. | −5.0 | 96.0 | 9.4 | 18.9 | 3.0 | |
| T 10-MW | ||||||
| Pre | 6.9 | 240.0 | 43.0 | 47.8 | 26.5 | |
| Post | 5.9 | 165.0 | 38.1 | 36.4 | 21,5 | |
| Mean diff. | −71.0 | 75.0 | 4.8 | 25.2 | 1.0 | |
| 6-MWT | ||||||
| Pre | 0.0 | 630.0 | 153.4 | 153.9 | 113.0 | |
| Post | 0.0 | 683.0 | 180.0 | 170.6 | 135.0 | |
| Mean diff. | −80.0 | 139.0 | 27.3 | 39.0 | 15.0 | |
| VAS | ||||||
| Pre | 0.0 | 10.0 | 3.0 | 3.4 | 0.0 | |
| Post | 0.0 | 9.0 | 1.7 | 2.4 | 0.0 | |
| Mean diff. | −3.0 | 8.0 | 1.2 | 2.1 | 0.0 | |
| WHO−5 | ||||||
| Pre | 20.0 | 100.0 | 62.8 | 21.9 | 70.0 | |
| Post | 28.0 | 100.0 | 78.4 | 16.6 | 80.0 | |
| Mean diff. | −4.0 | 48.0 | 15.5 | 15.0 | 12.0 |
BBS = Berg Balance Scale, TUG = Timed Up and Go, T 10-MW = Time to Travel 10 m, 6-MWT = 6-Minute Walk Test, VAS = Visual Analogue Scale, WHO-5 = WHO 5 Item Well-Being Index, Significance. level: * = p <0.001.
EuroQol Visual Analogue Scale and 5 Dimensions, pre- and post-intervention scores, showing the scores for EQ-VAS and frequency tables for EQ-5D.
| Min. | Max. | Mean | Sd | Median | |||
|---|---|---|---|---|---|---|---|
| EQ-VAS | |||||||
| Pre | 0.0 | 91.0 | 57.1 | 19.2 | 60.0 | ||
| Post | 20.0 | 95.0 | 66.1 | 15.4 | 65.0 | ||
| Mean diff. | –25.0 | 46.0 | 8.9 | 12.2 | 9.0 | ||
| Post | 0.0 | 1.0 | 2.0 | 3.0 | Total | ||
| EQ-5D Mobility | |||||||
| Pre | 0.0 | 0 | 0 | 0 | 0 | 0 | |
| 1.0 | 0 | 14 | 0 | 0 | 14 | ||
| 2.0 | 0 | 6 | 38 | 0 | 44 | ||
| 3.0 | 0 | 0 | 1 | 3 | 4 | ||
| Total | 0 | 20 | 39 | 3 | 62 | ||
| EQ-5D Self-care | |||||||
| Pre | 0.0 | 1 | 0 | 0 | 0 | 1 | |
| 1.0 | 0 | 30 | 1 | 0 | 31 | ||
| 2.0 | 0 | 2 | 18 | 3 | 23 | ||
| 3.0 | 0 | 0 | 3 | 4 | 7 | ||
| Total | 1 | 32 | 22 | 7 | 62 | ||
| EQ-5D Usual activities | |||||||
| Pre | 0.0 | 1 | 0 | 0 | 0 | 1 | |
| 1.0 | 0 | 15 | 4 | 1 | 20 | ||
| 2.0 | 0 | 8 | 19 | 1 | 28 | ||
| 3.0 | 0 | 3 | 3 | 7 | 13 | ||
| Total | 1 | 26 | 26 | 9 | 62 | ||
| EQ-5D Pain/discomfort | |||||||
| Pre | 0.0 | 1 | 1 | 0 | 0 | 2 | |
| 1.0 | 0 | 21 | 2 | 0 | 23 | ||
| 2.0 | 0 | 2 | 26 | 0 | 28 | ||
| 3.0 | 0 | 0 | 4 | 5 | 9 | ||
| Total | 1 | 24 | 32 | 5 | 62 | ||
| EQ-5D Anxiety/depression | |||||||
| Pre | 0.0 | 1 | 0 | 0 | 0 | 1 | |
| 1.0 | 1 | 30 | 3 | 0 | 34 | ||
| 2.0 | 0 | 6 | 17 | 0 | 23 | ||
| 3.0 | 0 | 0 | 1 | 3 | 4 | ||
| Total | 2 | 36 | 21 | 3 | 62 | ||
EQ-VAS = EuroQol Visual Analogue Scale, EQ-5D = EuroQol 5 Dimensions (0 = no problems; 1= slight problems; 2 = moderate problems and 3 = severe problems), Significance level: * = p < 0.001, ** = p < 0.05.